权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

RNA Dysregulation in ALS

ALS 中的 RNA 失调

基本信息

批准号：
7942819
负责人：
ROBERT B DARNELL
金额：
$ 49.76万
依托单位：
ROCKEFELLER UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-09-30 至 2011-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7942819
关键词：
Address Affect Aliquot American Amyotrophic Lateral Sclerosis Animals Autopsy Binding Sites Clinical Collection Complement Data Defect Development Diagnostic Disadvantaged Disease Exons Familial Amyotrophic Lateral Sclerosis Functional disorder Generations Genetic Variation Human Human Genetics Individual Intervention Laboratories Maps Mediating Methods MicroRNAs Modeling Motor Motor Neurons Mus Mutate Mutation Neocortex Neurons Pathogenesis Pathway interactions Patients Play RNA RNA Binding RNA Sequences RNA analysis RNA-Binding Proteins RNA-Protein Interaction Regulatory Pathway Role Sampling Site Techniques Technology Tissues Variant Work disease diagnosis genome wide association study genome-wide human tissue insight interest mouse model nervous system disorder next generation protein TDP-43 public health relevance research study stem therapeutic target

项目摘要

DESCRIPTION (provided by applicant): This is a proposal to explore the role of RNA dysregulation in the pathogenesis of amyotrophic lateral sclerosis (ALS). The work stems from recent findings that rare patients with familial ALS have mutations in RNA binding proteins. We will use newly developed methods to look at normal and abnormal RNA-protein interactions in tissues obtained from mouse models of ALS and from human ALS samples obtained at autopsy. This work has the potential to uncover new insights, as well as diagnostic markers and therapeutic targets for ALS. In addition, the use of new methods and paradigms will serve as a model for how to approach a growing list of neurologic disorders associated with RNA dysregulation. PUBLIC HEALTH RELEVANCE: This work is a study of a currently fatal human neurologic disorder that currently affects over 20,000 Americans. There is no means of diagnosing the disease short of clinical examination, and there is no treatment. The work offers the hope of understanding the cause, and of developing diagnostic markers and therapeutic targets for the disorder.

描述（由申请人提供）：这是一个探索RNA失调在肌萎缩侧索硬化（ALS）发病机制中的作用的建议。这项工作源于最近的发现，即罕见的家族性ALS患者在RNA结合蛋白中存在突变。我们将使用新开发的方法来研究从ALS小鼠模型和尸检获得的人类ALS样本中获得的组织中正常和异常的RNA-蛋白质相互作用。这项工作有可能揭示新的见解，以及ALS的诊断标志物和治疗靶点。此外，新方法和范例的使用将作为如何处理与RNA失调相关的神经系统疾病的模型。公共卫生相关性：这项工作是一项研究，目前致命的人类神经系统疾病，目前影响超过20,000美国人。除了临床检查外，没有诊断这种疾病的手段，也没有治疗方法。这项工作提供了了解原因的希望，并为这种疾病开发诊断标记和治疗靶点。